Synlogic Inc SYBX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/26/24 EDT
1.88quote price arrow up+0.02 (+1.08%)
Volume
3,832
52 week range
1.55 - 10.20
Loading...
  • Open1.88
  • Day High1.88
  • Day Low1.84
  • Prev Close1.86
  • 52 Week High10.20
  • 52 Week High Date05/09/23
  • 52 Week Low1.55
  • 52 Week Low Date02/13/24

Key Stats

  • Market Cap21.896M
  • Shares Out11.65M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • YTD % Change-51.43

KEY STATS

  • Open1.88
  • Day High1.88
  • Day Low1.84
  • Prev Close1.86
  • 52 Week High10.20
  • 52 Week High Date05/09/23
  • 52 Week Low1.55
  • 52 Week Low Date02/13/24
  • Market Cap21.896M
  • Shares Out11.65M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.02
  • YTD % Change-51.43

RATIOS/PROFITABILITY

  • EPS (TTM)-11.41
  • P/E (TTM)-0.16
  • Fwd P/E (NTM)-1.19
  • EBITDA (TTM)-53.203M
  • ROE (TTM)-91.46%
  • Revenue (TTM)3.371M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,699.26%
  • Debt To Equity (MRQ)0.01%

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Synlogic Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Synlogic, Inc. is a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases. The Company is focused on rare metabolic disorders, with its lead program, labafenogene marselecobac (SYNB1934), studied in Synpheny-3, a global, pivotal Phase 3 study for patients with phenylketonuria (PKU), and SYNB1353, a potential treatment for homocystinuria (HCU). The Company's early-stage pipeline includes product candidates for enteric hyperoxaluria...
Peter Barrett Ph.D.
Independent Chairman of the Board
Antoine Awad
Chief Operating Officer, Head of Technical Operation
Address
301 Binney St Ste 402
Cambridge, MA
02142-1030
United States

Top Peers

SYMBOLLASTCHG%CHG
GYRE
Gyre Therapeutics Inc
17.11+0.78+4.78%
LUMO
Lumos Pharma Inc
2.83+0.07+2.36%
DARE
Dare Bioscience Inc
0.3059+0.0167+5.7745%
OCX
OncoCyte Corp
2.48+0.04+1.64%
OMIC
Singular Genomics Systems Inc
0.4042+0.0036+0.8987%